Drug Research Institute
SCROLL DOWN
Focusing on the international development, aiming at the research and development frontier of new chemical drugs, SSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
Drug Research Institute of SSY Group Limited covers a total area of over 56,600 ㎡, with a construction area of more than 50,000 ㎡ and a fixed asset investment of more than 500 million RMB, including 200 million RMB of laboratory instruments and equipment. It has HPLC/UPLC, gas chromatograph, thermo ion chromatograph, Fourier Infrared spectrometer, X-ray diffractometer, brookraman spectrometer, Malvin particle size meter,ultra-high speed centrifuge, Agilent dissolution apparatus, PE differential scanning calorimeter, Agilent ICP-MS, GC-MS/MS, AB LC-MS/MS, Jena atomic absorption spectrophotometer and other advanced instruments and equipment.
-
56600
㎡Total floor area
-
50000
㎡Building area
-
500
millionInvestment in fixed assets
-
200
millionInstrument and equipment
Innovation, openness, inclusiveness and sharing
It has created a world-class R&D and innovation platform
National Enterprise Technology Center
Innovation demonstration enterprise
Post-Doctoral Research Center
Nobel Prize Expert Workstation
Reasonable and efficient R&D structure
New drug R&D Center
Solid preparations R&D Center
Liquid preparations R&D Center
APIs R&D Center
Quality inspection department
Registration affairs department
Patent affairs department
Scientific research management department
Information project approval department
Analysis Center
Medical center
Technology Transfer Center
Focus on frontier research of medicine
The company gathers international top medical experts, domestic industry senior experts and academic leaders of scientific research institutes, Led by doctors, the scientific research team with all kinds of cutting-edge talents as the backbone focuses on the frontier research of medicine
The high-level professional research teams of synthesis, analysis, preparations and APIs led by doctors and masters have established liquid preparation laboratories, solid preparation laboratories, jointly built laboratories with colleges and universities, and pilot laboratories. It has established high-level innovation platforms such as engineering laboratories and technology research centers jointly with Chinese Academy of Sciences, Zhejiang University, Tianjin University and other colleges and universities, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
First class experimental facilities and beautiful humanistic research environment complement each other
R&D experiment
R&D experiment
R&D experiment
Every year, it has cultivated more than 100 scientific research achievements in the treatment fields of anti-tumor, nervous system and cardiovascular system, as well as a number of national and provincial major scientific and technological innovation and industrialization projects.
Patent Certificate
The products studied mainly involve the treatment fields of respiratory system, neuropsychiatric system, digestive and metabolic system, anti-infection, cardiovascular system, basic infusion (including dialysis and flushing).
Patent certificate
Patent certificate
Patent certificate
Patent certificate
Patent certificate
Patent certificate
Innovative drug development pipeline
It involves tumor, autoimmune disease, organ fibrosis, anesthesia and analgesia, antiviral drugs and other fields.
Antineoplastic
Autoimmune disease
Organ fibrosis
Anesthetic analgesia
Antiviral drugs
Strategic cooperation with Professor Lu Tao of China Pharmaceutical University to develop new small molecule drugs in the fields of cancer, immunity and other diseases.
Strategic cooperation with Professor He Zhonggui of Shenyang Pharmaceutical University to develop advanced pharmaceutical products and improved new drugs.
Generic drug development
Generic drug development dosage forms
Diversified dosage forms ofparenteral administration products
★ Liposome, microsphere preparation
★ Parenteral emulsion
★ Special line preparation
★ Lyophilized preparation
★ Hormone injection
★ Large-volume injection
01
Diversified dosage forms of oral administration products
★ Regular release tablets
★ Sustained and controlled release tablets
★ Compound preparation
★ Capsules
★ Single dose suspension
★ Multi-dose suspension
02
Diversified dosage forms of other administration products
★ Inhalation preparation
★ Single dose eye drops
★ Dialysis solution
★ Irrigation solution
03
Lead the future by innovation
SSY Group Limited aims to become one of the “first echelon of pharmaceutical innovation” companies. It continuously strengthens innovation-driven development; it vigorously encourages the integration of production and research, strengthens and optimizes the five domains:new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs; and it promotes the cause of human health with strength from China!
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Copyright © 2021 SJZ No.4 Pharmaceutical 冀ICP备05007979号-1